Acknowledgement
The authors gratefully acknowledge the facility support provided by Urmia University of Medical Sciences.
References
- Miller LS, Fowler Jr VG, Shukla SK, Rose WE, Proctor RA. 2020. Development of a vaccine against Staphylococcus aureus invasive infections: Evidence based on human immunity, genetics and bacterial evasion mechanisms. FEMS Microbiol. Rev. 44: 123-153. https://doi.org/10.1093/femsre/fuz030
- Goudarzi M, Kobayashi N, Dadashi M, Pantucek R, Nasiri MJ, Fazeli M, et al. 2020. Prevalence, genetic diversity, and temporary shifts of inducible clindamycin resistance Staphylococcus aureus clones in Tehran, Iran: a molecular-epidemiological analysis from 2013 to 2018. Front. Microbiol. 11: 663. https://doi.org/10.3389/fmicb.2020.00663
- Yao W, Xu G, Li D, Bai B, Wang H, Cheng H, et al. 2019. Staphylococcus aureus with an erm-mediated constitutive macrolide-lincosamide-streptogramin B resistance phenotype has reduced susceptibility to the new ketolide, solithromycin. BMC Infect. Dis. 19: 175. https://doi.org/10.1186/s12879-019-3779-8
- Liu X, Deng S, Huang J, Huang Y, Zhang Y, Yan Q, et al. 2017. Dissemination of macrolides, fusidic acid and mupirocin resistance among Staphylococcus aureus clinical isolates. Oncotarget 8: 58086-58097. https://doi.org/10.18632/oncotarget.19491
- Sabate Bresco M, Harris LG, Thompson K, Stanic B, Morgenstern M, O'Mahony L, et al. 2017. Pathogenic mechanisms and host interactions in Staphylococcus epidermidis device-related infection. Front. Microbiol. 8: 1401. https://doi.org/10.3389/fmicb.2017.01401
- Juda M, Chudzik-Rzad B, Malm A. 2016. The prevalence of genotypes that determine resistance to macrolides, lincosamides, and streptogramins B compared with spiramycin susceptibility among erythromycin-resistant Staphylococcus epidermidis. Mem. Inst. Oswaldo Cruz. 111: 155-160. https://doi.org/10.1590/0074-02760150356
- Wayne P. 2017. Performance Standards for Antimicrobial Susceptibility Testing: Twenty-Seventh Informational Supplement M100-S27. Wayne, PA: CLSI.
- Tille P. 2017. Bailey & Scott's diagnostic microbiology-E-Book, pp. 252-261. Ed. Elsevier Health Sciences.
- Mendem SK, Gangadhara TA, Shivannavar CT, Gaddad SM. 2016. Antibiotic resistance patterns of Staphylococcus aureus: A multi center study from India. Microb. Pathog. 98: 167-170. https://doi.org/10.1016/j.micpath.2016.07.010
- Talebi G, Hashemia A, Goudarzi H, Shariati A, Bostanghadiri N, Sharahi JY, et al. 2019. Survey of ermA, ermB, ermC and mecA genes among Staphylococcus aureus isolates isolated from patients admitted to hospitals in Tehran, Iran by PCR and sequencing. Biomed. Res. 30: 259-263. https://doi.org/10.2220/biomedres.30.259
- Adhikari R, Shrestha S, Barakoti A, Amatya R. 2017. Inducible clindamycin and methicillin resistant Staphylococcus aureus in a tertiary care hospital, Kathmandu, Nepal. BMC Infect. Dis. 17: 483. https://doi.org/10.1186/s12879-017-2584-5
- Khashei R, Malekzadegan Y, Ebrahim-Saraie HS, Razavi Z. 2018. Phenotypic and genotypic characterization of macrolide, lincosamide and streptogramin B resistance among clinical isolates of staphylococci in southwest of Iran. BMC Res. Notes 11: 711. https://doi.org/10.1186/s13104-018-3817-4
- O'Connor C, Powell J, Finnegan C, O'gorman A, Barrett S, Hopkins K, et al. 2015. Incidence, management and outcomes of the first cfr-mediated linezolid-resistant Staphylococcus epidermidis outbreak in a tertiary referral centre in the Republic of Ireland. J. Hosp. Infect. 90: 316-321. https://doi.org/10.1016/j.jhin.2014.12.013
- Yoo IY, Kang O-K, Shim HJ, Huh HJ, Lee NY. 2020. Linezolid resistance in methicillin-resistant Staphylococcus aureus in Korea: High rate of false resistance to linezolid by the VITEK 2 system. Ann. Lab. Med. 40: 57-62. https://doi.org/10.3343/alm.2020.40.1.57
- Ruiz-Ripa L, Fessler AT, Hanke D, Eichhorn I, Azcona-Gutierrez JM, Alonso CA, et al. 2021. Mechanisms of linezolid resistance among clinical Staphylococcus spp. in Spain: Spread of methicillin-and linezolid-resistant S. epidermidis ST2. Microb. Drug Res. 27: 145-153. https://doi.org/10.1089/mdr.2020.0122
- Musumeci R, Calaresu E, Gerosa J, Oggioni D, Bramati S, Morelli P, et al. 2016. Resistance to linezolid in Staphylococcus spp. clinical isolates associated with ribosomal binding site modifications: novel mutation in domain V of 23S rRNA. New Microbiol. 39: 269-273.
- Majhi S, Dash M, Mohapatra D, Mohapatra A, Chayani N. 2016. Detection of inducible and constitutive clindamycin resistance among Staphylococcus aureus isolates in a tertiary care hospital, Eastern India. Avicenna J. Med. 6: 75-80. https://doi.org/10.4103/2231-0770.184066
- Ejikeugwu C, Nwezeagu F, Edeh C, Eze P. 2018. Detection of constitutive and inducible-clindamycin-resistance in clinical isolates of Staphylococcus aureus from a Federal Teaching Hospital in Abakaliki, Nigeria. J. Bacteriol. Infect. Dis. 2: 31-34.
- Jarajreh Da, Aqel A, Alzoubi H, Al-Zereini W. 2017. Prevalence of inducible clindamycin resistance in methicillin-resistant Staphylococcus aureus: the first study in Jordan. J. Infect. Dev. Ctries. 11: 350-354. https://doi.org/10.3855/jidc.8316
- da Paz Pereira JN, Rabelo MA, da Costa Lima JL, Neto AMB, de Souza Lopes AC, Maciel MAV. 2016. Phenotypic and molecular characterization of resistance to macrolides, lincosamides and type B streptogramin of clinical isolates of Staphylococcus spp. of a university hospital in Recife, Pernambuco, Brazil. Braz. J. Infect. Dis. 20: 276-281. https://doi.org/10.1016/j.bjid.2016.03.003